Wei-Sen Lam Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series — Best of the Best Orals - Lung Cancer